Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-14-023164
Filing Date
2014-03-27
Accepted
2014-03-27 10:56:46
Documents
1
Period of Report
2014-03-25

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3325
  Complete submission text file 0001104659-14-023164.txt   5108
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Reporting) CIK: 0001121404 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50743 | Film No.: 14720568
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations